LivaNova (LIVN) Amortization of Goodwill (2022)

LivaNova (LIVN) reported Amortization of Goodwill of $4000.0 for Q4 2022, down 100.0% sequentially from $129.4 million in Q3 2022.

LivaNova (LIVN) Amortization of Goodwill (2022) Analysis & Trends

LivaNova (LIVN) has 1 years of Amortization of Goodwill data on file, last reported at $4000.0 in Q4 2022.

For the quarter ending Q4 2022, Amortization of Goodwill changed N/A year-over-year to $4000.0; the trailing twelve-month figure through Dec 2023 stood at $129.4 million (changed 0.0% YoY), and the FY2022 full-year result was $129.4 million, changed N/A from the prior year.
Amortization of Goodwill fell to $4000.0 in Q4 2022, from $129.4 million in the prior quarter.
In the past five years, Amortization of Goodwill ranged from a high of $129.4 million in Q3 2022 to a low of $4000.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.88 Bn	176.59 Bn	6.27 Bn
2	Stryker	128.94 Bn	126.06 Bn	3.81 Bn
3	Medtronic	108.75 Bn	99.53 Bn	6.41 Bn
4	Boston Scientific	68.65 Bn	67.19 Bn	3.61 Bn
5	Edwards Lifesciences	48.22 Bn	44.55 Bn	1.29 Bn
6	Dexcom	28.43 Bn	27.31 Bn	750.30 Mn
7	GE HealthCare Technologies	28.32 Bn	26.03 Bn	1.98 Bn
8	Smith & Nephew	26.91 Bn	26.33 Bn	-
9	Koninklijke Philips	25.10 Bn	21.98 Bn	2.07 Bn
10	LivaNova	4.38 Bn	3.84 Bn	243.75 Mn

Download Data